Skip to content
healthcare.dev
Get a free key

Litfulo

NDC 0069-0334, ritlecitinib, capsule, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0069-0334
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215830
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RITLECITINIB TOSYLATE50 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Janus Kinase 3 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Tyrosine Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0069-0334-280006903342828 CAPSULE in 1 BOTTLE (0069-0334-28)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6b2f9446-fb23-4741-b73a-5a2f993733c3

Use it

Look up 0069-0334 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0334 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0069-0334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.